Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties. - Lichun Ma; Debby Dan Wang; Yiqing Huang; Maria P. Wong; Victor H. F. Lee; Hong Yan 001 (Comput. Biol. Medicine, 2015)

Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis. - Bin Zou 004; Victor H. F. Lee; Hong Yan 001 (BMC Bioinform., 2018)

Molecular subtyping of cancer: current status and moving toward clinical applications. - Lan Zhao 004; Victor H. F. Lee; Michael K. Ng 001; Hong Yan 001; Maarten F. Bijlsma (Briefings Bioinform., 2019)

Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects. - Rizwan Qureshi; Bin Zou 004; Tanvir Alam; Jia Wu 009; Victor H. F. Lee; Hong Yan 001 (IEEE ACM Trans. Comput. Biol. Bioinform., 2023)

Developing a named entity framework for thyroid cancer staging and risk level classification using large language models. - Matrix M. H. Fung; Eric H. M. Tang; Tingting Wu; Yan Luk; Ivan C. H. Au; Xiaodong Liu; Victor H. F. Lee; Chun Ka Wong; Zhili Wei; Wing Yiu Cheng; Isaac C. Y. Tai; Joshua W. K. Ho; et al. (npj Digit. Medicine, 2025)